Hasan Uncu

Hasan Uncu

Auto-generated profile, based on publicly available information

Hasan Uncu

UNIVERSITY OF HEALTH SCIENCES, ADANA NUMUNE HEALTH RESEARCH CENTER, DEPARTMENT OF SURGICAL MEDICAL SCIENCES, DEPARTMENT OF CARDIOVASCULAR SURGERY

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2000 in The American Journal of Cardiology
Verified
Journal Article
Closed access
KÇKerim Çağli
Kerim Çağli
MGM.KAmil Göl
M.KAmil Göl
TKTelat Keles
Telat Keles
EŞErol Şener
Erol Şener
ÜYÜlkü Yildiz
Ülkü Yildiz
KBKemal Bayazit
Kemal Bayazit

10 May 2024 in Medicine
Verified
Journal Article
Open access
HUHasan Uncu
Hasan Uncu
TBTolga Onur BADAK
Tolga Onur BADAK
HUHaci Ali Ucak
Haci Ali Ucak
FCFerid Cereb
Ferid Cereb
ACAhmet Cakallioglu
Ahmet Cakallioglu
Warfarin, a widely utilized anticoagulant, is paramount for preventing thromboembolic events in patients with mechanical heart valve replacements. However, its narrow therapeutic index can lead to over-anticoagulation and overdose, resulting in serious health risks. This study examines the efficacy of human prothrombin complex concentrate (PCC) in managing warfarin overdose, in comparison with traditional treatments. A retrospective analysis was conducted on 162 adults who presented with warfarin overdose (INR > 5.0) at a tertiary care hospital between 2016 and 2020. Participants were divided into 2 groups—those treated with PCC (n = 57) and those treated with conventional methods (n = 105), including vitamin K and fresh frozen plasma. The primary outcome was the rate of reaching the target (International Normalized Ratio) INR within 24 hours. Secondary outcomes included transfusion requirements, thromboembolic events, adverse reactions, 30-day mortality, and length of hospital stay. PCC demonstrated significant efficacy, with 89.5% of patients achieving the target INR within 24 hours, compared to 64.8% in the control group ( P < .05). The PCC group also had reduced transfusion requirements and a shorter average hospital stay. There was no significant difference in thromboembolic events or adverse reactions between the 2 groups, and the reduced 30-day mortality in the PCC group was not statistically significant. Human prothrombin complex concentrate is associated with rapid reaching the target INR, decreased transfusion needs, and shortened hospitalization, making it a promising option for warfarin overdose management. While the results are encouraging, larger, multicenter, randomized controlled trials are necessary to further validate these findings and optimize PCC administration protocols.

17 March 2026 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Closed access
FCFerid Cereb
Ferid Cereb
TBTolga Onur BADAK
Tolga Onur BADAK
AÇAhmet Çakallıoğlu
Ahmet Çakallıoğlu
HUHacı Ali Uçak
Hacı Ali Uçak
HUHasan Uncu
Hasan Uncu
Objective: This study evaluates the mid- and long-term anatomical success, safety, and clinical outcomes of cyanoacrylate embolization (CAE), a non-thermal endovenous ablation method, for symptomatic isolated small saphenous vein (SSV) insufficiency.Methods: Data from 230 patients (300 extremities) who underwent CAE between January 2019 and December 2024 were retrospectively analyzed. Venous Clinical Severity Score (VCSS), Aberdeen Varicose Vein Questionnaire (AVVQ), and Visual Analog Scale (VAS) pain scores were recorded at 1, 6, 12, 24, and 60 months. Primary outcome was complete vein occlusion rate at 12 months confirmed by color Doppler ultrasound (DUS). Secondary outcomes included complications and changes in clinical scores.Results: Mean patient age was 48.5 ± 12.2 years; 67.4% were female. Most common CEAP class was C3 (33.9%). Complete occlusion rate at 12 months was 98.0% (294/300 extremities), maintained at 97.0% at 60 months. Mean pre-procedural VCSS (8.4 ± 2.1), AVVQ (18.1 ± 4.5), and VAS (7.8 ± 1.3) scores decreased to 2.1 ± 1.5, 5.3 ± 2.8, and 1.2 ± 0.9 at 12 months (p

30 June 2024 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Open access
PDF file
TBTolga Onur BADAK
Tolga Onur BADAK
FCFerid Cereb
Ferid Cereb
HUHacı Ali Uçak
Hacı Ali Uçak
HUHasan Uncu
Hasan Uncu
OOOzge Ozalp
Ozge Ozalp
OBOzlem Boz
Ozlem Boz
Aim: Warfarin, a widely prescribed anticoagulant, exhibits considerable variability in patient response, making its clinical use challenging due to a narrow therapeutic window. This study aimed to evaluate the prevalence of CYP2C9 and VKORC1 gene polymorphisms in a cohort of 87 Turkish patients who underwent cardiac valve surgery and received warfarin therapy, as well as to assess their impact on warfarin dosage requirements. Methods: The frequencies of CYP2C9 and VKORC1 polymorphisms were analyzed, and patients were stratified based on the presence or absence of mutations affecting warfarin dosing. Results: Revealed that patients carrying at least one CYP2C9 or VKORC1 polymorphism required a significantly lower weekly warfarin dose to achieve the optimal international normalized ratio (INR). Conclusion: This study highlights the critical role of genetic factors in determining warfarin dosage and supports the integration of pharmacogenetic testing into clinical practice to personalize warfarin therapy. Such an approach has the potential to enhance treatment outcomes and minimize the risk of adverse events. Further research involving larger sample sizes and diverse patient populations is warranted to validate these findings and refine the current understanding of the genetic determinants of warfarin dosing.

31 December 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Verified
Journal Article
Closed access
TBTolga Onur BADAK
Tolga Onur BADAK
FCFerid Cereb
Ferid Cereb
AÇAhmet Çakallıoğlu
Ahmet Çakallıoğlu
HUHacı Ali Uçak
Hacı Ali Uçak
HUHasan Uncu
Hasan Uncu
Aim: It aims to retrospectively evaluate the relationship between preoperative neutrophil-lymphocyte ratio (NLR) values and the incidence of postoperative complications in patients undergoing heart valve replacement. Material and Methods: This retrospective cohort study examined the data of 412 adult patients undergoing elective aortic and/or mitral valve replacement. NLR was calculated from blood samples 24 hours before surgery. Patients were divided into two groups based on NLR values: Group 1: NLR < 3.0 and Group 2: NLR ≥ 3.0. Results: According to preoperative NLR values, 268 patients (65%) were in Group 1 and 144 patients (35%) were in Group 2. Significantly higher rates of postoperative atrial fibrillation (PoAF), renal dysfunction, prolonged mechanical ventilation, and infectious complications were observed in Group 2 compared to Group 1. Conclusion: It demonstrates that preoperative NLR may be a simple and effective tool for risk stratification in patients undergoing valve surgery.